Comparative analysis of dimension reduction methods for cytometry by time-of-flight data K Wang, Y Yang, F Wu, B Song, X Wang, T Wang Nature communications 14 (1), 1836, 2023 | 28 | 2023 |
Loss of SYNCRIP unleashes APOBEC-driven mutagenesis, tumor heterogeneity, and AR-targeted therapy resistance in prostate cancer X Li, Y Wang, S Deng, G Zhu, C Wang, NA Johnson, Z Zhang, CR Tirado, ... Cancer cell 41 (8), 1427-1449. e12, 2023 | 27 | 2023 |
Interpreting the B-cell receptor repertoire with single-cell gene expression using Benisse Z Zhang, WY Chang, K Wang, Y Yang, X Wang, C Yao, T Wu, L Wang, ... Nature Machine Intelligence 4 (6), 596-604, 2022 | 19 | 2022 |
UBE2J1 is the E2 ubiquitin-conjugating enzyme regulating androgen receptor degradation and antiandrogen resistance C Rodriguez Tirado, C Wang, X Li, S Deng, J Gonzalez, NA Johnson, ... Oncogene 43 (4), 265-280, 2024 | 8 | 2024 |
ZNF397 deficiency triggers TET2-driven lineage plasticity and AR-targeted therapy resistance in prostate cancer Y Xu, Y Yang, Z Wang, M Sjöström, Y Jiang, Y Tang, S Cheng, S Deng, ... Cancer discovery 14 (8), 1496-1521, 2024 | 7 | 2024 |
Cytomulate: accurate and efficient simulation of CyTOF data Y Yang, K Wang, Z Lu, T Wang, X Wang Genome biology 24 (1), 262, 2023 | 3 | 2023 |
pan-MHC and cross-species prediction of T cell receptor-antigen binding Y Han, Y Yang, Y Tian, FJ Fattah, MS Itzstein, M Zhang, X Kang, DM Yang, ... bioRxiv, 2023.12. 01.569599, 2023 | 1 | 2023 |
Bayesian and Deep Generative Modeling in Immunology Y Yang Southern Methodist University, 2024 | | 2024 |
Highly variable timing renders immunotherapy efficacy and toxicity impractical biomarkers of one another in clinical practice MS Von Itzstein, Y Yang, Y Wang, D Hsiehchen, TY Sheffield, F Fattah, ... Frontiers in immunology 15, 1351739, 2024 | | 2024 |
MetaNorm: incorporating meta-analytic priors into normalization of NanoString nCounter data J Barth, Y Yang, G Xiao, X Wang Bioinformatics 40 (1), btae024, 2024 | | 2024 |
Systemic immune parameters after prior radiation therapy in patients receiving immune checkpoint inhibitors V Mundra, Y Yang, MS von Itzstein, F Fattah, AS Gonugunta, R Hannan, ... Translational Oncology 34, 101689, 2023 | | 2023 |